Noam Solomon

Noam Solomon is the CEO and co-founder at Immunai, the first company set to reprogram the immune system for better detection, diagnosis, and treatment of disease, and discovery of novel therapeutics.

Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam has a double Ph.D., in Math and Computer Science and served as a post-doctoral researcher in the Mathematics department at the Massachusetts Institute of Technology, and in the Center of Mathematical Sciences and Applications at Harvard University.

Noam also worked as an algorithms developer and a data scientist, consultant, and head of data science in several hi-tech companies in Israel.